A volcanic explosion of autoantibodies in systemic lupus erythematosus: A diversity of 180 different antibodies found in SLE patients
Recent research in systemic lupus erythematosus (SLE) yielded new antigens and antibodies in SLE patients. We describe the various autoantibodies that can be detected in patients with SLE. A literature review, using the terms “autoantibody” and “systemic lupus erythematosus”, was conducted to search...
Saved in:
| Published in | Autoimmunity reviews Vol. 14; no. 1; pp. 75 - 79 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
01.01.2015
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1568-9972 1873-0183 |
| DOI | 10.1016/j.autrev.2014.10.003 |
Cover
| Abstract | Recent research in systemic lupus erythematosus (SLE) yielded new antigens and antibodies in SLE patients. We describe the various autoantibodies that can be detected in patients with SLE.
A literature review, using the terms “autoantibody” and “systemic lupus erythematosus”, was conducted to search for articles on autoantibodies in SLE, their target antigens, association with disease activity and other clinical manifestations.
One hundred and eighty autoantibodies were so far described in SLE patients. These include autoantibodies that target nuclear antigens, cytoplasmic antigens, cell membrane antigens, phospholipid-associated antigens, blood cells, endothelial cells, and nervous system antigens, plasma proteins, matrix proteins, and miscellaneous antigens. The target of an autoantibody, the autoantigen properties, autoantibody frequencies in SLE, as well as clinical associations, and correlation with disease activity are described for all 180 autoantibodies.
SLE is so far the autoimmune disease with the largest number of detectable autoantibodies. Their production could be antigen-driven, the result of a polyclonal B cell activation, impaired apoptotic pathways, or the outcome of an idiotypic network dysregulation. |
|---|---|
| AbstractList | Recent research in systemic lupus erythematosus (SLE) yielded new antigens and antibodies in SLE patients. We describe the various autoantibodies that can be detected in patients with SLE. A literature review, using the terms "autoantibody" and "systemic lupus erythematosus", was conducted to search for articles on autoantibodies in SLE, their target antigens, association with disease activity and other clinical manifestations. One hundred and eighty autoantibodies were so far described in SLE patients. These include autoantibodies that target nuclear antigens, cytoplasmic antigens, cell membrane antigens, phospholipid-associated antigens, blood cells, endothelial cells, and nervous system antigens, plasma proteins, matrix proteins, and miscellaneous antigens. The target of an autoantibody, the autoantigen properties, autoantibody frequencies in SLE, as well as clinical associations, and correlation with disease activity are described for all 180 autoantibodies. SLE is so far the autoimmune disease with the largest number of detectable autoantibodies. Their production could be antigen-driven, the result of a polyclonal B cell activation, impaired apoptotic pathways, or the outcome of an idiotypic network dysregulation. Recent research in systemic lupus erythematosus (SLE) yielded new antigens and antibodies in SLE patients. We describe the various autoantibodies that can be detected in patients with SLE. A literature review, using the terms “autoantibody” and “systemic lupus erythematosus”, was conducted to search for articles on autoantibodies in SLE, their target antigens, association with disease activity and other clinical manifestations. One hundred and eighty autoantibodies were so far described in SLE patients. These include autoantibodies that target nuclear antigens, cytoplasmic antigens, cell membrane antigens, phospholipid-associated antigens, blood cells, endothelial cells, and nervous system antigens, plasma proteins, matrix proteins, and miscellaneous antigens. The target of an autoantibody, the autoantigen properties, autoantibody frequencies in SLE, as well as clinical associations, and correlation with disease activity are described for all 180 autoantibodies. SLE is so far the autoimmune disease with the largest number of detectable autoantibodies. Their production could be antigen-driven, the result of a polyclonal B cell activation, impaired apoptotic pathways, or the outcome of an idiotypic network dysregulation. Abstract Recent research in systemic lupus erythematosus (SLE) yielded new antigens and antibodies in SLE patients. We describe the various autoantibodies that can be detected in patients with SLE. A literature review, using the terms “autoantibody” and “systemic lupus erythematosus”, was conducted to search for articles on autoantibodies in SLE, their target antigens, association with disease activity and other clinical manifestations. One hundred and eighty autoantibodies were so far described in SLE patients. These include autoantibodies that target nuclear antigens, cytoplasmic antigens, cell membrane antigens, phospholipid-associated antigens, blood cells, endothelial cells, and nervous system antigens, plasma proteins, matrix proteins, and miscellaneous antigens. The target of an autoantibody, the autoantigen properties, autoantibody frequencies in SLE, as well as clinical associations, and correlation with disease activity are described for all 180 autoantibodies. SLE is so far the autoimmune disease with the largest number of detectable autoantibodies. Their production could be antigen-driven, the result of a polyclonal B cell activation, impaired apoptotic pathways, or the outcome of an idiotypic network dysregulation. |
| Author | Shor, Dana Ben-Ami Welt, Mike Slonimsky, Einat Twig, Gilad Lotan, Eyal Mozes, Oshry Klang, Eyal Sherer, Yaniv Amital, Howard Furer, Ariel Komisar, Orna Yaniv, Gal Marai, Ibrahim Shoenfeld, Yehuda Shina, Avi |
| Author_xml | – sequence: 1 givenname: Gal surname: Yaniv fullname: Yaniv, Gal organization: Department of Imaging, The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel – sequence: 2 givenname: Gilad surname: Twig fullname: Twig, Gilad organization: Department of Medicine ‘B’, The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel – sequence: 3 givenname: Dana Ben-Ami surname: Shor fullname: Shor, Dana Ben-Ami organization: Department of Medicine ‘B’, The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel – sequence: 4 givenname: Ariel surname: Furer fullname: Furer, Ariel organization: The Israel Defense Forces Medical Corps, Israel – sequence: 5 givenname: Yaniv surname: Sherer fullname: Sherer, Yaniv organization: The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel – sequence: 6 givenname: Oshry surname: Mozes fullname: Mozes, Oshry organization: Department of Imaging, The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel – sequence: 7 givenname: Orna surname: Komisar fullname: Komisar, Orna organization: Department of Imaging, The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel – sequence: 8 givenname: Einat surname: Slonimsky fullname: Slonimsky, Einat organization: Department of Imaging, The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel – sequence: 9 givenname: Eyal surname: Klang fullname: Klang, Eyal organization: Department of Imaging, The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel – sequence: 10 givenname: Eyal surname: Lotan fullname: Lotan, Eyal organization: Department of Imaging, The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel – sequence: 11 givenname: Mike surname: Welt fullname: Welt, Mike organization: Department of Medicine ‘B’, The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel – sequence: 12 givenname: Ibrahim surname: Marai fullname: Marai, Ibrahim organization: Department of Cardiology, Rambam Medical Center, Haifa, Israel – sequence: 13 givenname: Avi surname: Shina fullname: Shina, Avi organization: Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Israel – sequence: 14 givenname: Howard surname: Amital fullname: Amital, Howard organization: Department of Medicine ‘B’, The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel – sequence: 15 givenname: Yehuda surname: Shoenfeld fullname: Shoenfeld, Yehuda email: shoenfel@post.tau.ac.il organization: The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25449682$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkl2L1DAYhYOsuB_6D0Ry6U3HJE3bZBFhWNYPGPBi9Tqk6RvM2CZjkg7bH-D_NmVWEUG9SnhzzvPCOblEZz54QOg5JRtKaPtqv9FzjnDcMEJ5GW0IqR-hCyq6uiJU1Gfl3rSikrJj5-gypT0pNsnkE3TOGs5lK9gF-r7FxzAa7Z3BcH8YQ3LB42BxgQfts-vD4CBh53FaUoap6Mb5MCcMcclfYNI5pDld4y0e3BFicnlZ7VSQMrAWIviMfwPZMPthxd3tbvFBZ1fe01P02OoxwbOH8wp9fnv76eZ9tfv47sPNdleZhvJcdS1vasl624mOSWNE3TaEtX0r7NCzQQ8wDNCSmmsDILq-6aUVLZWWm1pqaeor9PLEPcTwbYaU1eSSgXHUHsKcFG15V2KkDS_SFw_SuZ9gUIfoJh0X9TO6IuAngYkhpQj2l4QStTak9urUkFobWqcFXWzXf9iMyyWG4HPUbvyf-c3JDCWko4OozOhKdXr8CgukfZijL_kpqhJTRN2tH2Dtn3JCGG1EAbz-O0ANwf17_w8H4cUL |
| CitedBy_id | crossref_primary_10_1016_j_tibtech_2020_07_003 crossref_primary_10_4110_in_2022_22_e37 crossref_primary_10_4078_jrd_2016_23_4_199 crossref_primary_10_1177_09612033211004726 crossref_primary_10_1016_j_jtauto_2022_100143 crossref_primary_10_3389_fimmu_2018_02836 crossref_primary_10_1007_s12026_016_8886_7 crossref_primary_10_1111_eci_12744 crossref_primary_10_1016_j_jtauto_2022_100145 crossref_primary_10_1016_j_autrev_2018_02_011 crossref_primary_10_1016_j_heliyon_2024_e30767 crossref_primary_10_1111_jdv_13769 crossref_primary_10_1016_j_intimp_2020_106648 crossref_primary_10_1074_jbc_M115_647008 crossref_primary_10_1093_hmg_ddad062 crossref_primary_10_13181_mji_v26i4_1899 crossref_primary_10_1515_cclm_2018_0052 crossref_primary_10_1111_sji_12452 crossref_primary_10_18632_oncotarget_15192 crossref_primary_10_1007_s40674_019_00122_0 crossref_primary_10_1016_j_gpb_2018_11_004 crossref_primary_10_3389_fimmu_2019_00064 crossref_primary_10_3389_fimmu_2019_02241 crossref_primary_10_1038_s41598_020_78223_3 crossref_primary_10_3389_fimmu_2020_02139 crossref_primary_10_1002_acr2_11745 crossref_primary_10_1080_08916934_2020_1801651 crossref_primary_10_3390_epigenomes4020006 crossref_primary_10_4049_jimmunol_1800300 crossref_primary_10_3389_fimmu_2022_764557 crossref_primary_10_3390_biomedicines8050097 crossref_primary_10_1038_s41598_017_08099_3 crossref_primary_10_3389_fendo_2018_00742 crossref_primary_10_1016_j_autrev_2015_07_017 crossref_primary_10_1002_art_41047 crossref_primary_10_1016_j_ejpsy_2023_100224 crossref_primary_10_1016_j_gpb_2015_09_001 crossref_primary_10_1016_j_ebiom_2021_103504 crossref_primary_10_1177_0961203319828521 crossref_primary_10_1177_0961203320959696 crossref_primary_10_1016_j_autrev_2015_03_003 crossref_primary_10_1177_0961203319868531 crossref_primary_10_21518_2079_701X_2019_9_92_95 crossref_primary_10_3389_fimmu_2019_00538 crossref_primary_10_1155_2019_8450947 crossref_primary_10_1136_ard_2022_223808 crossref_primary_10_1016_j_eurpsy_2017_03_006 crossref_primary_10_1136_lupus_2022_000732 crossref_primary_10_3390_ijms232112855 crossref_primary_10_3109_08916934_2015_1090985 crossref_primary_10_1016_j_autrev_2019_03_013 crossref_primary_10_1016_j_clinbiochem_2023_110600 crossref_primary_10_1155_2015_328078 crossref_primary_10_1016_j_autrev_2015_07_003 crossref_primary_10_3389_fimmu_2022_850759 crossref_primary_10_3390_ijms20163878 crossref_primary_10_1016_j_jtauto_2022_100155 crossref_primary_10_1177_0961203317713141 crossref_primary_10_1371_journal_pone_0196103 crossref_primary_10_1007_s13317_018_0102_4 crossref_primary_10_7555_JBR_38_20240009 crossref_primary_10_1038_s41392_020_0139_5 crossref_primary_10_3389_fimmu_2021_808839 crossref_primary_10_1002_ccr3_3140 crossref_primary_10_1016_j_autrev_2020_102588 crossref_primary_10_1111_1346_8138_16813 crossref_primary_10_1016_j_clim_2018_10_004 crossref_primary_10_1111_sji_12366 crossref_primary_10_1016_j_pnpbp_2024_110993 crossref_primary_10_1080_23808993_2018_1448266 crossref_primary_10_1515_cclm_2016_0197 crossref_primary_10_3389_fimmu_2021_735105 crossref_primary_10_1177_0961203318788153 crossref_primary_10_1186_s13075_024_03301_0 crossref_primary_10_1016_j_autrev_2015_11_014 crossref_primary_10_1097_BOR_0000000000000922 crossref_primary_10_7759_cureus_50229 crossref_primary_10_3389_fimmu_2022_1034336 crossref_primary_10_1016_j_tibs_2022_09_011 crossref_primary_10_1186_s40478_017_0473_1 crossref_primary_10_15369_sujms_34_225 crossref_primary_10_2147_ITT_S450184 crossref_primary_10_1016_j_autrev_2016_01_019 crossref_primary_10_37349_ei_2022_00055 crossref_primary_10_47360_1995_4484_2023_513_530 crossref_primary_10_1016_j_yexcr_2024_114381 crossref_primary_10_1016_j_clim_2022_109109 crossref_primary_10_1016_j_autrev_2016_06_003 crossref_primary_10_1155_2021_5538643 crossref_primary_10_3390_biom8040105 crossref_primary_10_3390_antib8020035 crossref_primary_10_1074_mcp_RA119_001582 crossref_primary_10_1007_s12026_018_9044_1 crossref_primary_10_1136_lupus_2020_000384 crossref_primary_10_15252_emmm_202215864 crossref_primary_10_1002_art_42082 crossref_primary_10_1080_15321819_2022_2099225 crossref_primary_10_1016_j_autrev_2015_04_004 crossref_primary_10_3389_fimmu_2021_625311 crossref_primary_10_1177_0961203315624023 crossref_primary_10_1016_j_parint_2020_102057 crossref_primary_10_1177_0961203316628999 crossref_primary_10_3390_cimb46080509 crossref_primary_10_3389_fimmu_2019_02112 crossref_primary_10_4049_jimmunol_1900043 crossref_primary_10_1016_j_apsb_2016_07_001 crossref_primary_10_1080_15321819_2021_1895215 crossref_primary_10_3389_fimmu_2019_01026 crossref_primary_10_1007_s12026_016_8814_x crossref_primary_10_1016_j_autrev_2019_102450 crossref_primary_10_1177_0961203317719334 crossref_primary_10_1007_s12016_016_8576_1 crossref_primary_10_1016_j_smim_2019_101339 crossref_primary_10_1136_annrheumdis_2019_216535 crossref_primary_10_1371_journal_pone_0226883 crossref_primary_10_1016_j_rdc_2017_06_003 crossref_primary_10_3390_diagnostics12030647 crossref_primary_10_3889_oamjms_2022_7487 crossref_primary_10_1016_j_jaut_2018_02_009 crossref_primary_10_1093_rheumatology_key149 crossref_primary_10_1016_j_autrev_2015_10_003 crossref_primary_10_1016_j_biopha_2024_117289 crossref_primary_10_3389_fimmu_2021_681105 crossref_primary_10_1016_j_jim_2018_05_014 crossref_primary_10_1021_acs_jproteome_2c00799 crossref_primary_10_3389_fimmu_2023_1080154 crossref_primary_10_1136_lupus_2023_000942 crossref_primary_10_1177_0961203317722846 crossref_primary_10_3233_HAB_180359 crossref_primary_10_1007_s12026_018_9045_0 crossref_primary_10_1016_j_freeradbiomed_2020_12_006 crossref_primary_10_1016_j_intimp_2023_110968 crossref_primary_10_1093_rheumatology_kez623 crossref_primary_10_1016_j_autrev_2024_103610 crossref_primary_10_1007_s11427_015_4953_x crossref_primary_10_1111_cei_13512 crossref_primary_10_1038_srep27623 crossref_primary_10_1002_cti2_1408 crossref_primary_10_7759_cureus_38666 crossref_primary_10_3389_fimmu_2022_928623 crossref_primary_10_3390_cells10123523 crossref_primary_10_1016_j_clinbiochem_2021_11_009 crossref_primary_10_1038_ni_3209 crossref_primary_10_1111_imm_13418 crossref_primary_10_1016_j_jaut_2017_07_003 crossref_primary_10_3390_diagnostics12082026 crossref_primary_10_1016_j_autrev_2015_02_008 crossref_primary_10_1136_annrheumdis_2017_211388 crossref_primary_10_3389_fimmu_2024_1502712 crossref_primary_10_1016_j_jaut_2020_102486 crossref_primary_10_3389_fimmu_2020_587380 crossref_primary_10_1016_j_jtauto_2025_100274 crossref_primary_10_1007_s12026_023_09396_y crossref_primary_10_1016_j_heliyon_2024_e29230 crossref_primary_10_1016_j_imlet_2016_03_004 crossref_primary_10_1016_j_msard_2019_101452 crossref_primary_10_4049_jimmunol_1601565 crossref_primary_10_1016_j_ebiom_2015_05_027 crossref_primary_10_1177_0961203320944473 crossref_primary_10_1016_j_cytogfr_2018_12_001 crossref_primary_10_2217_bmm_2023_0774 crossref_primary_10_1007_s00262_025_03975_8 crossref_primary_10_3389_fimmu_2020_00343 crossref_primary_10_1016_j_isci_2021_103537 crossref_primary_10_3389_fimmu_2019_01104 crossref_primary_10_1007_s10067_021_06034_6 crossref_primary_10_1186_s13075_022_02980_x crossref_primary_10_1007_s10067_018_4124_0 crossref_primary_10_3390_antib6030009 crossref_primary_10_1016_j_jaut_2016_02_003 crossref_primary_10_1007_s11538_024_01291_3 crossref_primary_10_1111_imm_13879 crossref_primary_10_1016_j_aca_2017_04_008 crossref_primary_10_3389_fimmu_2021_679613 crossref_primary_10_1016_j_jtauto_2021_100139 crossref_primary_10_1177_09612033241260231 crossref_primary_10_1016_j_jaci_2023_05_011 crossref_primary_10_46833_reumatologiasp_2017_16_2_6_13 crossref_primary_10_1021_acsnano_6b03786 crossref_primary_10_1016_j_jaut_2015_03_001 crossref_primary_10_23736_S1825_859X_22_00141_4 crossref_primary_10_4103_ijd_ijd_18_23 crossref_primary_10_1517_14712598_2016_1171840 crossref_primary_10_1016_j_autrev_2020_102508 crossref_primary_10_1016_j_imlet_2025_107002 crossref_primary_10_1016_j_autrev_2024_103718 crossref_primary_10_3389_fimmu_2023_1321228 crossref_primary_10_3389_fimmu_2024_1408718 crossref_primary_10_3390_antib5010002 crossref_primary_10_1016_j_dnarep_2017_06_020 crossref_primary_10_14412_1995_4484_2018_302_309 crossref_primary_10_1097_MD_0000000000020192 crossref_primary_10_1155_2015_745647 crossref_primary_10_1038_nrneph_2015_33 crossref_primary_10_1016_j_trsl_2024_08_004 crossref_primary_10_1093_cvr_cvab329 crossref_primary_10_1016_j_ekir_2018_11_005 crossref_primary_10_1016_j_it_2020_03_004 crossref_primary_10_3389_fimmu_2021_724047 crossref_primary_10_3109_14397595_2015_1074649 crossref_primary_10_1126_sciadv_abo5840 crossref_primary_10_1177_0961203319897127 crossref_primary_10_1007_s00109_016_1421_4 crossref_primary_10_1007_s10072_024_07895_w crossref_primary_10_1002_eji_202250109 crossref_primary_10_1016_j_cca_2020_05_005 crossref_primary_10_1016_j_autrev_2018_03_013 crossref_primary_10_1371_journal_pone_0174200 crossref_primary_10_1002_acr2_11149 crossref_primary_10_1007_s12016_016_8567_2 crossref_primary_10_1016_j_jtauto_2023_100191 crossref_primary_10_1136_lupus_2021_000605 crossref_primary_10_1111_imr_12374 crossref_primary_10_3892_mmr_2021_12529 crossref_primary_10_3390_antib13010010 crossref_primary_10_1186_s13075_017_1380_3 crossref_primary_10_1186_s43042_024_00488_4 crossref_primary_10_4049_jimmunol_1600624 crossref_primary_10_3389_fimmu_2022_1051779 crossref_primary_10_1111_cei_12889 crossref_primary_10_3390_biom14040416 crossref_primary_10_1016_j_amjms_2018_06_022 crossref_primary_10_1177_0961203316641770 crossref_primary_10_1007_s12016_017_8608_5 crossref_primary_10_1016_j_autrev_2017_11_009 crossref_primary_10_1016_j_berh_2017_10_003 crossref_primary_10_1016_j_imlet_2023_06_005 crossref_primary_10_1080_00365513_2017_1339232 crossref_primary_10_1161_HYPERTENSIONAHA_117_10473 crossref_primary_10_1155_2016_8252605 crossref_primary_10_3390_cells9040915 crossref_primary_10_1093_rheumatology_kez634 crossref_primary_10_3389_fimmu_2018_02090 crossref_primary_10_3389_fimmu_2020_569234 crossref_primary_10_1016_j_beem_2019_101369 crossref_primary_10_1084_jem_20210322 crossref_primary_10_1002_art_41812 crossref_primary_10_1007_s12016_017_8601_z crossref_primary_10_1016_j_semarthrit_2017_03_022 crossref_primary_10_3389_fimmu_2021_686501 crossref_primary_10_1007_s12016_021_08918_6 crossref_primary_10_1016_j_autrev_2017_05_009 crossref_primary_10_1136_jclinpath_2015_203455 crossref_primary_10_3390_ijms20205183 crossref_primary_10_1136_lupus_2017_000206 crossref_primary_10_1038_s41598_024_59726_9 crossref_primary_10_5114_aoms_176941 |
| Cites_doi | 10.1191/0961203303lu1071oa 10.1016/j.jaut.2009.12.009 10.1016/j.jaut.2011.05.007 10.1016/j.autrev.2010.05.004 10.1056/NEJMra1100359 10.1172/JCI105669 10.1016/j.autrev.2007.11.022 10.1016/j.jaut.2007.02.012 10.1038/nm1101-1189 10.1016/j.autrev.2008.06.003 10.1016/j.autrev.2007.02.001 10.1097/00002281-200109000-00007 10.1016/j.jaut.2005.01.002 10.3109/s10165-012-0707-9 10.1002/art.1780330502 10.1002/art.21414 10.1016/j.autrev.2011.10.020 10.1159/000047970 10.4049/jimmunol.175.8.5516 10.1056/NEJMoa021933 10.1038/nm.1892 10.1016/j.autrev.2010.09.007 10.1007/s12016-007-8060-z 10.1073/pnas.88.8.3069 10.4049/jimmunol.142.9.3076 10.1002/1529-0131(199910)42:10<2026::AID-ANR2>3.0.CO;2-J 10.1016/j.autrev.2010.12.008 10.1016/j.semarthrit.2004.07.002 10.1016/j.berh.2005.04.003 10.1016/j.jaut.2007.11.011 10.1007/s00415-003-0223-0 10.1016/j.autrev.2011.10.021 10.1191/096120300678828695 10.1073/pnas.0608397104 10.1002/art.22419 10.1016/j.semarthrit.2006.11.003 10.1002/art.1780210301 10.1046/j.1365-2249.2000.01154.x 10.1006/jaut.1998.0219 10.1002/art.22031 10.1186/1471-2474-11-13 10.1093/rheumatology/kem181 |
| ContentType | Journal Article |
| Copyright | 2014 Elsevier B.V. Elsevier B.V. Copyright © 2014 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2014 Elsevier B.V. – notice: Elsevier B.V. – notice: Copyright © 2014 Elsevier B.V. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 |
| DOI | 10.1016/j.autrev.2014.10.003 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts |
| DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1873-0183 |
| EndPage | 79 |
| ExternalDocumentID | 25449682 10_1016_j_autrev_2014_10_003 1_s2_0_S1568997214002158 S1568997214002158 |
| Genre | Journal Article Review |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1~. 1~5 23N 4.4 457 4G. 53G 5GY 5VS 6J9 7-5 71M 8P~ AAAJQ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BLXMC BNPGV CJTIS CS3 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM LUGTX M41 MO0 N9A O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. Q38 ROL RPZ SCC SDF SDG SES SEW SPCBC SSH SSI SSZ T5K UHS UNMZH UV1 Z5R ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7T5 ACLOT EFLBG H94 ~HD |
| ID | FETCH-LOGICAL-c514t-7645392bf78729cc8365026b68fdb2dadedde6034acee87b5b9f8619f4c39a9c3 |
| ISSN | 1568-9972 |
| IngestDate | Sat Sep 27 22:55:54 EDT 2025 Tue Jul 04 17:19:42 EDT 2023 Tue Jul 01 04:28:38 EDT 2025 Thu Apr 24 22:58:47 EDT 2025 Sun Feb 23 10:18:52 EST 2025 Tue Aug 26 16:32:12 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Autoantibodies Systemic lupus erythematosus |
| Language | English |
| License | Copyright © 2014 Elsevier B.V. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c514t-7645392bf78729cc8365026b68fdb2dadedde6034acee87b5b9f8619f4c39a9c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 25449682 |
| PQID | 1647003154 |
| PQPubID | 23462 |
| PageCount | 5 |
| ParticipantIDs | proquest_miscellaneous_1647003154 pubmed_primary_25449682 crossref_primary_10_1016_j_autrev_2014_10_003 crossref_citationtrail_10_1016_j_autrev_2014_10_003 elsevier_clinicalkeyesjournals_1_s2_0_S1568997214002158 elsevier_clinicalkey_doi_10_1016_j_autrev_2014_10_003 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2015-01-01 |
| PublicationDateYYYYMMDD | 2015-01-01 |
| PublicationDate_xml | – month: 01 year: 2015 text: 2015-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Autoimmunity reviews |
| PublicationTitleAlternate | Autoimmun Rev |
| PublicationYear | 2015 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Kowal, Degiorgio, Lee, Edgar, Huerta, Volpe (bb0115) 2006 Dec 26; 103 Sherer, Gorstein, Fritzler, Shoenfeld (bb0030) 2004 Oct; 34 Wichmann, Respaldiza, Garcia-Lozano, Montes, Sanchez-Roman, Nunez-Roldan (bb0060) 2000 Mar; 119 Huizinga, Steens, van Buchem (bb0190) 2001 Sep; 13 DeGiorgio, Konstantinov, Lee, Hardin, Volpe, Diamond (bb0165) 2001 Nov; 7 Gualtierotti, Biggioggero, Penatti, Meroni (bb0160) 2010 Nov; 10 Munoz, Gaipl, Herrmann (bb0055) 2008 Sep; 7 Chen, Zhao, Zhang, Wang (bb0070) 2004; 13 Raz, Brezis, Rosenmann, Eilat (bb0095) 1989 May 1; 142 Arbuckle, McClain, Rubertone, Scofield, Dennis, James (bb0010) 2003 Oct 16; 349 Sanna, Piga, Terryberry, Peltz, Giagheddu, Satta (bb0205) 2000; 9 Buyon, Winchester (bb0080) 1990 May; 33 Reichlin (bb0125) 1998 Oct; 11 Wootla, Lacroix-Desmazes, Warrington, Bieber, Kaveri, Rodriguez (bb0045) 2011 Sep; 37 Sibbitt, Sibbitt, Brooks (bb0185) 1999 Oct; 42 Rothfield, Stollar (bb0085) 1967 Nov; 46 Rekvig, Putterman, Casu, Gao, Ghirardello, Mortensen (bb0035) 2012 Jun; 11 Winfield, Brunner, Koffler (bb0090) 1978 Apr; 21 Lee, Huerta, Zhang, Kowal, Bertini, Volpe (bb0120) 2009 Jan; 15 Zandman-Goddard, Chapman, Shoenfeld (bb0140) 2007 Apr; 36 Tobon, Youinou, Saraux (bb0040) 2010 Aug; 35 Renaudineau, Deocharan, Jousse, Renaudineau, Putterman, Youinou (bb0110) 2007 Aug; 6 Shoenfeld, Twig, Katz, Sherer (bb0020) 2008 Feb-Mar; 30 Fauchais, Martel, Gondran, Lambert, Launay, Jauberteau (bb0050) 2010 Jul; 9 To, Petri (bb0155) 2005 Dec; 52 Katsumata, Harigai, Kawaguchi, Fukasawa, Soejima, Kanno (bb0180) 2010; 11 Csepany, Bereczki, Kollar, Sikula, Kiss, Csiba (bb0210) 2003 Nov; 250 Tsokos (bb0065) 2011 Dec 1; 365 Amital, Heilweil-Harel, Ulmansky, Harlev, Toubi, Hershko (bb0105) 2007 Sep; 46 Shoenfeld, Gilburd, Abu-Shakra, Amital, Barzilai, Berkun (bb0025) 2008 Jan; 10 Miyawaki, Nishiyama, Aita, Yoshinaga (bb0075) 2013 Jul; 23 Lapteva, Nowak, Yarboro, Takada, Roebuck-Spencer, Weickert (bb0170) 2006 Aug; 54 Castellino, Govoni, Giacuzzo, Trotta (bb0200) 2008 Feb; 7 Amital, Heilweil, Ulmansky, Szafer, Bar-Tana, Morel (bb0100) 2005 Oct 15; 175 Blank, Cohen, Toder, Shoenfeld (bb0150) 1991 Apr 15; 88 Shoenfeld (bb0130) 2007 Mar-May; 28 Sun, Tang, Chen, Lee, Feng, Yu (bb0135) 2005 Mar; 24 Agmon-Levin, Mosca, Petri, Shoenfeld (bb0015) 2012 Jun; 11 Katzav, Solodeev, Brodsky, Chapman, Pick, Blank (bb0145) 2007 Mar; 56 Appenzeller, Pike, Clarke (bb0195) 2008 Jun; 34 Mosca, Tani, Aringer, Bombardieri, Boumpas, Cervera (bb0005) 2011 May; 10 Hanly, Harrison (bb0175) 2005 Oct; 19 Kumral, Evyapan, Keser, Kabasakal, Oksel, Aksu (bb0215) 2002; 47 Lapteva (10.1016/j.autrev.2014.10.003_bb0170) 2006; 54 Castellino (10.1016/j.autrev.2014.10.003_bb0200) 2008; 7 Zandman-Goddard (10.1016/j.autrev.2014.10.003_bb0140) 2007; 36 Shoenfeld (10.1016/j.autrev.2014.10.003_bb0020) 2008; 30 Kowal (10.1016/j.autrev.2014.10.003_bb0115) 2006; 103 Agmon-Levin (10.1016/j.autrev.2014.10.003_bb0015) 2012; 11 Arbuckle (10.1016/j.autrev.2014.10.003_bb0010) 2003; 349 Lee (10.1016/j.autrev.2014.10.003_bb0120) 2009; 15 DeGiorgio (10.1016/j.autrev.2014.10.003_bb0165) 2001; 7 Huizinga (10.1016/j.autrev.2014.10.003_bb0190) 2001; 13 Mosca (10.1016/j.autrev.2014.10.003_bb0005) 2011; 10 Sherer (10.1016/j.autrev.2014.10.003_bb0030) 2004; 34 Fauchais (10.1016/j.autrev.2014.10.003_bb0050) 2010; 9 Shoenfeld (10.1016/j.autrev.2014.10.003_bb0025) 2008; 10 Chen (10.1016/j.autrev.2014.10.003_bb0070) 2004; 13 Wootla (10.1016/j.autrev.2014.10.003_bb0045) 2011; 37 Tobon (10.1016/j.autrev.2014.10.003_bb0040) 2010; 35 Renaudineau (10.1016/j.autrev.2014.10.003_bb0110) 2007; 6 Hanly (10.1016/j.autrev.2014.10.003_bb0175) 2005; 19 To (10.1016/j.autrev.2014.10.003_bb0155) 2005; 52 Reichlin (10.1016/j.autrev.2014.10.003_bb0125) 1998; 11 Sanna (10.1016/j.autrev.2014.10.003_bb0205) 2000; 9 Gualtierotti (10.1016/j.autrev.2014.10.003_bb0160) 2010; 10 Sun (10.1016/j.autrev.2014.10.003_bb0135) 2005; 24 Katsumata (10.1016/j.autrev.2014.10.003_bb0180) 2010; 11 Miyawaki (10.1016/j.autrev.2014.10.003_bb0075) 2013; 23 Rekvig (10.1016/j.autrev.2014.10.003_bb0035) 2012; 11 Munoz (10.1016/j.autrev.2014.10.003_bb0055) 2008; 7 Rothfield (10.1016/j.autrev.2014.10.003_bb0085) 1967; 46 Shoenfeld (10.1016/j.autrev.2014.10.003_bb0130) 2007; 28 Winfield (10.1016/j.autrev.2014.10.003_bb0090) 1978; 21 Wichmann (10.1016/j.autrev.2014.10.003_bb0060) 2000; 119 Amital (10.1016/j.autrev.2014.10.003_bb0105) 2007; 46 Kumral (10.1016/j.autrev.2014.10.003_bb0215) 2002; 47 Blank (10.1016/j.autrev.2014.10.003_bb0150) 1991; 88 Sibbitt (10.1016/j.autrev.2014.10.003_bb0185) 1999; 42 Csepany (10.1016/j.autrev.2014.10.003_bb0210) 2003; 250 Appenzeller (10.1016/j.autrev.2014.10.003_bb0195) 2008; 34 Amital (10.1016/j.autrev.2014.10.003_bb0100) 2005; 175 Katzav (10.1016/j.autrev.2014.10.003_bb0145) 2007; 56 Tsokos (10.1016/j.autrev.2014.10.003_bb0065) 2011; 365 Raz (10.1016/j.autrev.2014.10.003_bb0095) 1989; 142 Buyon (10.1016/j.autrev.2014.10.003_bb0080) 1990; 33 |
| References_xml | – volume: 46 start-page: 1785 year: 1967 Nov end-page: 1794 ident: bb0085 article-title: The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus publication-title: J Clin Invest – volume: 13 start-page: 383 year: 2001 Sep end-page: 388 ident: bb0190 article-title: Imaging modalities in central nervous system systemic lupus erythematosus publication-title: Curr Opin Rheumatol – volume: 23 start-page: 659 year: 2013 Jul end-page: 666 ident: bb0075 article-title: The effect of methotrexate on improving serological abnormalities of patients with systemic lupus erythematosus publication-title: Mod Rheumatol – volume: 10 start-page: 3 year: 2010 Nov end-page: 7 ident: bb0160 article-title: Updating on the pathogenesis of systemic lupus erythematosus publication-title: Autoimmun Rev – volume: 47 start-page: 131 year: 2002 end-page: 135 ident: bb0215 article-title: Detection of microembolic signals in patients with neuropsychiatric lupus erythematosus publication-title: Eur Neurol – volume: 250 start-page: 1348 year: 2003 Nov end-page: 1354 ident: bb0210 article-title: MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension publication-title: J Neurol – volume: 103 start-page: 19854 year: 2006 Dec 26 end-page: 19859 ident: bb0115 article-title: Human lupus autoantibodies against NMDA receptors mediate cognitive impairment publication-title: Proc Natl Acad Sci U S A – volume: 11 start-page: 557 year: 1998 Oct end-page: 561 ident: bb0125 article-title: Cellular dysfunction induced by penetration of autoantibodies into living cells: cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins publication-title: J Autoimmun – volume: 52 start-page: 4003 year: 2005 Dec end-page: 4010 ident: bb0155 article-title: Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? publication-title: Arthritis Rheum – volume: 88 start-page: 3069 year: 1991 Apr 15 end-page: 3073 ident: bb0150 article-title: Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies publication-title: Proc Natl Acad Sci U S A – volume: 56 start-page: 938 year: 2007 Mar end-page: 948 ident: bb0145 article-title: Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system publication-title: Arthritis Rheum – volume: 10 start-page: 383 year: 2011 May end-page: 388 ident: bb0005 article-title: Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice publication-title: Autoimmun Rev – volume: 11 start-page: 596 year: 2012 Jun end-page: 603 ident: bb0035 article-title: Autoantibodies in lupus: culprits or passive bystanders? publication-title: Autoimmun Rev – volume: 175 start-page: 5516 year: 2005 Oct 15 end-page: 5523 ident: bb0100 article-title: Treatment with a laminin-derived peptide suppresses lupus nephritis publication-title: J Immunol – volume: 35 start-page: 10 year: 2010 Aug end-page: 14 ident: bb0040 article-title: The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis publication-title: J Autoimmun – volume: 21 start-page: 289 year: 1978 Apr end-page: 294 ident: bb0090 article-title: Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction publication-title: Arthritis Rheum – volume: 34 start-page: 501 year: 2004 Oct end-page: 537 ident: bb0030 article-title: Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients publication-title: Semin Arthritis Rheum – volume: 33 start-page: 609 year: 1990 May end-page: 614 ident: bb0080 article-title: Congenital complete heart block. A human model of passively acquired autoimmune injury publication-title: Arthritis Rheum – volume: 13 start-page: 584 year: 2004 end-page: 589 ident: bb0070 article-title: Antineutrophil autoantibodies and their target antigens in systemic lupus erythematosus publication-title: Lupus – volume: 19 start-page: 799 year: 2005 Oct end-page: 821 ident: bb0175 article-title: Management of neuropsychiatric lupus publication-title: Best Pract Res Clin Rheumatol – volume: 7 start-page: 297 year: 2008 Feb end-page: 304 ident: bb0200 article-title: Optimizing clinical monitoring of central nervous system involvement in SLE publication-title: Autoimmun Rev – volume: 10 start-page: 3 year: 2008 Jan end-page: 7 ident: bb0025 article-title: The mosaic of autoimmunity: genetic factors involved in autoimmune diseases—2008 publication-title: Isr Med Assoc J – volume: 36 start-page: 297 year: 2007 Apr end-page: 315 ident: bb0140 article-title: Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome publication-title: Semin Arthritis Rheum – volume: 24 start-page: 135 year: 2005 Mar end-page: 143 ident: bb0135 article-title: Monoclonal ribosomal P autoantibody inhibits the expression and release of IL-12, TNF-alpha and iNOS in activated RAW macrophage cell line publication-title: J Autoimmun – volume: 42 start-page: 2026 year: 1999 Oct end-page: 2038 ident: bb0185 article-title: Neuroimaging in neuropsychiatric systemic lupus erythematosus publication-title: Arthritis Rheum – volume: 28 start-page: 165 year: 2007 Mar-May end-page: 169 ident: bb0130 article-title: To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system publication-title: J Autoimmun – volume: 11 start-page: 13 year: 2010 ident: bb0180 article-title: Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study publication-title: BMC Musculoskelet Disord – volume: 46 start-page: 1433 year: 2007 Sep end-page: 1437 ident: bb0105 article-title: Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption publication-title: Rheumatology (Oxford) – volume: 7 start-page: 1189 year: 2001 Nov end-page: 1193 ident: bb0165 article-title: A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus publication-title: Nat Med – volume: 54 start-page: 2505 year: 2006 Aug end-page: 2514 ident: bb0170 article-title: Anti-N-methyl- publication-title: Arthritis Rheum – volume: 365 start-page: 2110 year: 2011 Dec 1 end-page: 2121 ident: bb0065 article-title: Systemic lupus erythematosus publication-title: N Engl J Med – volume: 34 start-page: 361 year: 2008 Jun end-page: 366 ident: bb0195 article-title: Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus publication-title: Clin Rev Allergy Immunol – volume: 11 start-page: 593 year: 2012 Jun end-page: 595 ident: bb0015 article-title: Systemic lupus erythematosus one disease or many? publication-title: Autoimmun Rev – volume: 7 start-page: 594 year: 2008 Sep end-page: 597 ident: bb0055 article-title: Predictive value of anti-dsDNA autoantibodies: importance of the assay publication-title: Autoimmun Rev – volume: 30 start-page: 74 year: 2008 Feb-Mar end-page: 83 ident: bb0020 article-title: Autoantibody explosion in antiphospholipid syndrome publication-title: J Autoimmun – volume: 37 start-page: 144 year: 2011 Sep end-page: 150 ident: bb0045 article-title: Autoantibodies with enzymatic properties in human autoimmune diseases publication-title: J Autoimmun – volume: 9 start-page: 573 year: 2000 end-page: 583 ident: bb0205 article-title: Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations publication-title: Lupus – volume: 9 start-page: 595 year: 2010 Jul end-page: 599 ident: bb0050 article-title: Immunological profile in primary Sjogren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease publication-title: Autoimmun Rev – volume: 142 start-page: 3076 year: 1989 May 1 end-page: 3082 ident: bb0095 article-title: Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney publication-title: J Immunol – volume: 349 start-page: 1526 year: 2003 Oct 16 end-page: 1533 ident: bb0010 article-title: Development of autoantibodies before the clinical onset of systemic lupus erythematosus publication-title: N Engl J Med – volume: 119 start-page: 530 year: 2000 Mar end-page: 532 ident: bb0060 article-title: Autoantibodies to DEK oncoprotein in systemic lupus erythematosus (SLE) publication-title: Clin Exp Immunol – volume: 15 start-page: 91 year: 2009 Jan end-page: 96 ident: bb0120 article-title: Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus publication-title: Nat Med – volume: 6 start-page: 464 year: 2007 Aug end-page: 468 ident: bb0110 article-title: Anti-alpha-actinin antibodies: a new marker of lupus nephritis publication-title: Autoimmun Rev – volume: 13 start-page: 584 issue: 8 year: 2004 ident: 10.1016/j.autrev.2014.10.003_bb0070 article-title: Antineutrophil autoantibodies and their target antigens in systemic lupus erythematosus publication-title: Lupus doi: 10.1191/0961203303lu1071oa – volume: 35 start-page: 10 issue: 1 year: 2010 ident: 10.1016/j.autrev.2014.10.003_bb0040 article-title: The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis publication-title: J Autoimmun doi: 10.1016/j.jaut.2009.12.009 – volume: 37 start-page: 144 issue: 2 year: 2011 ident: 10.1016/j.autrev.2014.10.003_bb0045 article-title: Autoantibodies with enzymatic properties in human autoimmune diseases publication-title: J Autoimmun doi: 10.1016/j.jaut.2011.05.007 – volume: 9 start-page: 595 issue: 9 year: 2010 ident: 10.1016/j.autrev.2014.10.003_bb0050 article-title: Immunological profile in primary Sjogren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2010.05.004 – volume: 365 start-page: 2110 issue: 22 year: 2011 ident: 10.1016/j.autrev.2014.10.003_bb0065 article-title: Systemic lupus erythematosus publication-title: N Engl J Med doi: 10.1056/NEJMra1100359 – volume: 46 start-page: 1785 issue: 11 year: 1967 ident: 10.1016/j.autrev.2014.10.003_bb0085 article-title: The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus publication-title: J Clin Invest doi: 10.1172/JCI105669 – volume: 7 start-page: 297 issue: 4 year: 2008 ident: 10.1016/j.autrev.2014.10.003_bb0200 article-title: Optimizing clinical monitoring of central nervous system involvement in SLE publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2007.11.022 – volume: 28 start-page: 165 issue: 2-3 year: 2007 ident: 10.1016/j.autrev.2014.10.003_bb0130 article-title: To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system publication-title: J Autoimmun doi: 10.1016/j.jaut.2007.02.012 – volume: 7 start-page: 1189 issue: 11 year: 2001 ident: 10.1016/j.autrev.2014.10.003_bb0165 article-title: A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus publication-title: Nat Med doi: 10.1038/nm1101-1189 – volume: 7 start-page: 594 issue: 8 year: 2008 ident: 10.1016/j.autrev.2014.10.003_bb0055 article-title: Predictive value of anti-dsDNA autoantibodies: importance of the assay publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2008.06.003 – volume: 6 start-page: 464 issue: 7 year: 2007 ident: 10.1016/j.autrev.2014.10.003_bb0110 article-title: Anti-alpha-actinin antibodies: a new marker of lupus nephritis publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2007.02.001 – volume: 13 start-page: 383 issue: 5 year: 2001 ident: 10.1016/j.autrev.2014.10.003_bb0190 article-title: Imaging modalities in central nervous system systemic lupus erythematosus publication-title: Curr Opin Rheumatol doi: 10.1097/00002281-200109000-00007 – volume: 24 start-page: 135 issue: 2 year: 2005 ident: 10.1016/j.autrev.2014.10.003_bb0135 article-title: Monoclonal ribosomal P autoantibody inhibits the expression and release of IL-12, TNF-alpha and iNOS in activated RAW macrophage cell line publication-title: J Autoimmun doi: 10.1016/j.jaut.2005.01.002 – volume: 23 start-page: 659 issue: 4 year: 2013 ident: 10.1016/j.autrev.2014.10.003_bb0075 article-title: The effect of methotrexate on improving serological abnormalities of patients with systemic lupus erythematosus publication-title: Mod Rheumatol doi: 10.3109/s10165-012-0707-9 – volume: 33 start-page: 609 issue: 5 year: 1990 ident: 10.1016/j.autrev.2014.10.003_bb0080 article-title: Congenital complete heart block. A human model of passively acquired autoimmune injury publication-title: Arthritis Rheum doi: 10.1002/art.1780330502 – volume: 52 start-page: 4003 issue: 12 year: 2005 ident: 10.1016/j.autrev.2014.10.003_bb0155 article-title: Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? publication-title: Arthritis Rheum doi: 10.1002/art.21414 – volume: 11 start-page: 593 issue: 8 year: 2012 ident: 10.1016/j.autrev.2014.10.003_bb0015 article-title: Systemic lupus erythematosus one disease or many? publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2011.10.020 – volume: 47 start-page: 131 issue: 3 year: 2002 ident: 10.1016/j.autrev.2014.10.003_bb0215 article-title: Detection of microembolic signals in patients with neuropsychiatric lupus erythematosus publication-title: Eur Neurol doi: 10.1159/000047970 – volume: 175 start-page: 5516 issue: 8 year: 2005 ident: 10.1016/j.autrev.2014.10.003_bb0100 article-title: Treatment with a laminin-derived peptide suppresses lupus nephritis publication-title: J Immunol doi: 10.4049/jimmunol.175.8.5516 – volume: 349 start-page: 1526 issue: 16 year: 2003 ident: 10.1016/j.autrev.2014.10.003_bb0010 article-title: Development of autoantibodies before the clinical onset of systemic lupus erythematosus publication-title: N Engl J Med doi: 10.1056/NEJMoa021933 – volume: 15 start-page: 91 issue: 1 year: 2009 ident: 10.1016/j.autrev.2014.10.003_bb0120 article-title: Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus publication-title: Nat Med doi: 10.1038/nm.1892 – volume: 10 start-page: 3 issue: 1 year: 2010 ident: 10.1016/j.autrev.2014.10.003_bb0160 article-title: Updating on the pathogenesis of systemic lupus erythematosus publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2010.09.007 – volume: 34 start-page: 361 issue: 3 year: 2008 ident: 10.1016/j.autrev.2014.10.003_bb0195 article-title: Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus publication-title: Clin Rev Allergy Immunol doi: 10.1007/s12016-007-8060-z – volume: 88 start-page: 3069 issue: 8 year: 1991 ident: 10.1016/j.autrev.2014.10.003_bb0150 article-title: Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.88.8.3069 – volume: 142 start-page: 3076 issue: 9 year: 1989 ident: 10.1016/j.autrev.2014.10.003_bb0095 article-title: Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney publication-title: J Immunol doi: 10.4049/jimmunol.142.9.3076 – volume: 42 start-page: 2026 issue: 10 year: 1999 ident: 10.1016/j.autrev.2014.10.003_bb0185 article-title: Neuroimaging in neuropsychiatric systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/1529-0131(199910)42:10<2026::AID-ANR2>3.0.CO;2-J – volume: 10 start-page: 383 issue: 7 year: 2011 ident: 10.1016/j.autrev.2014.10.003_bb0005 article-title: Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2010.12.008 – volume: 34 start-page: 501 issue: 2 year: 2004 ident: 10.1016/j.autrev.2014.10.003_bb0030 article-title: Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2004.07.002 – volume: 10 start-page: 3 issue: 1 year: 2008 ident: 10.1016/j.autrev.2014.10.003_bb0025 article-title: The mosaic of autoimmunity: genetic factors involved in autoimmune diseases—2008 publication-title: Isr Med Assoc J – volume: 19 start-page: 799 issue: 5 year: 2005 ident: 10.1016/j.autrev.2014.10.003_bb0175 article-title: Management of neuropsychiatric lupus publication-title: Best Pract Res Clin Rheumatol doi: 10.1016/j.berh.2005.04.003 – volume: 30 start-page: 74 issue: 1-2 year: 2008 ident: 10.1016/j.autrev.2014.10.003_bb0020 article-title: Autoantibody explosion in antiphospholipid syndrome publication-title: J Autoimmun doi: 10.1016/j.jaut.2007.11.011 – volume: 250 start-page: 1348 issue: 11 year: 2003 ident: 10.1016/j.autrev.2014.10.003_bb0210 article-title: MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension publication-title: J Neurol doi: 10.1007/s00415-003-0223-0 – volume: 11 start-page: 596 issue: 8 year: 2012 ident: 10.1016/j.autrev.2014.10.003_bb0035 article-title: Autoantibodies in lupus: culprits or passive bystanders? publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2011.10.021 – volume: 9 start-page: 573 issue: 8 year: 2000 ident: 10.1016/j.autrev.2014.10.003_bb0205 article-title: Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations publication-title: Lupus doi: 10.1191/096120300678828695 – volume: 103 start-page: 19854 issue: 52 year: 2006 ident: 10.1016/j.autrev.2014.10.003_bb0115 article-title: Human lupus autoantibodies against NMDA receptors mediate cognitive impairment publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0608397104 – volume: 56 start-page: 938 issue: 3 year: 2007 ident: 10.1016/j.autrev.2014.10.003_bb0145 article-title: Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system publication-title: Arthritis Rheum doi: 10.1002/art.22419 – volume: 36 start-page: 297 issue: 5 year: 2007 ident: 10.1016/j.autrev.2014.10.003_bb0140 article-title: Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2006.11.003 – volume: 21 start-page: 289 issue: 3 year: 1978 ident: 10.1016/j.autrev.2014.10.003_bb0090 article-title: Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction publication-title: Arthritis Rheum doi: 10.1002/art.1780210301 – volume: 119 start-page: 530 issue: 3 year: 2000 ident: 10.1016/j.autrev.2014.10.003_bb0060 article-title: Autoantibodies to DEK oncoprotein in systemic lupus erythematosus (SLE) publication-title: Clin Exp Immunol doi: 10.1046/j.1365-2249.2000.01154.x – volume: 11 start-page: 557 issue: 5 year: 1998 ident: 10.1016/j.autrev.2014.10.003_bb0125 article-title: Cellular dysfunction induced by penetration of autoantibodies into living cells: cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins publication-title: J Autoimmun doi: 10.1006/jaut.1998.0219 – volume: 54 start-page: 2505 issue: 8 year: 2006 ident: 10.1016/j.autrev.2014.10.003_bb0170 article-title: Anti-N-methyl-d-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.22031 – volume: 11 start-page: 13 year: 2010 ident: 10.1016/j.autrev.2014.10.003_bb0180 article-title: Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study publication-title: BMC Musculoskelet Disord doi: 10.1186/1471-2474-11-13 – volume: 46 start-page: 1433 issue: 9 year: 2007 ident: 10.1016/j.autrev.2014.10.003_bb0105 article-title: Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kem181 |
| SSID | ssj0016929 |
| Score | 2.5488222 |
| SecondaryResourceType | review_article |
| Snippet | Recent research in systemic lupus erythematosus (SLE) yielded new antigens and antibodies in SLE patients. We describe the various autoantibodies that can be... Abstract Recent research in systemic lupus erythematosus (SLE) yielded new antigens and antibodies in SLE patients. We describe the various autoantibodies that... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 75 |
| SubjectTerms | Allergy and Immunology Animals Autoantibodies Autoantibodies - analysis Autoantibodies - immunology Autoantigens - immunology Humans Lupus Erythematosus, Systemic - immunology Systemic lupus erythematosus |
| Title | A volcanic explosion of autoantibodies in systemic lupus erythematosus: A diversity of 180 different antibodies found in SLE patients |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1568997214002158 https://www.clinicalkey.es/playcontent/1-s2.0-S1568997214002158 https://www.ncbi.nlm.nih.gov/pubmed/25449682 https://www.proquest.com/docview/1647003154 |
| Volume | 14 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdpymAvY9_LPooGewsKji1_aG9eyFa2rpS1hb4J2ZapS2aXOt7o3vcX7R_cybIUhzR064tJhD59P9-dTqc7hN45HhOCph6hUZoRKrKcwN-cUKUNCOkzoaN9Hgb7p_TzmX82GPzpeS01y2SS_rrxXsldqAplQFd1S_Y_KGs7hQL4DfSFJ1AYnv9E43gMzAXeTZGqSP2Lqu60P9EsK3hjRVIpH0Fl0tABm6Heorls6rG8utbRWqu6qfXl9KzvoDGNHJs6Rbmg265ylYVJdXh8MDcxWeu-ghvD0EV75wR66kKdWs4CM_3RGuLFyq_jZ9Eym0_FQmTW3HOujQgASTH-IEsSfy8s0BqTgBs2-Yu-0WLq94wWHZ8NgM-ycJ0R0w3Aaa6qc6t08lnnntng_NoIcaH8flTyHhiUTlq3PW8l6czp_nz2ZUpqd-KQYzURNQ_YZyrtJ1qvrLdJvHa5wzeq7qBdNwSFbYh249m3gyN7eBWwNjmeXaO5sdm6FW7Ob5tGtG3H02o-Jw_Rg27LgmONv0doIMvH6J5OYnr9BP2OsUEhtijEVY7XUYiLEhsU4haFeA2F73GMLQZVc8AgthjEvY5aDKruAIPYYPApOv04P5ntky65B0lBR1-SMKA-6OZJDhLDZWkaecAd3CAJojxL3ExkEgRv4HhUgBoXhYmfsDyC3X4OjIUJlnrP0LCsSvkCYRllgoZsGiW-Q5NwyjLpuzSVWRgFLEzpCHnmBfO0i3yvErAsuHFxvOCaLFyRRZUCWUaI2FaXOvLLLfV9QztubjWDHOYA0FvahTe1k3XHaGq-DYAj9NZAhINQUCd9opRVAy0CGipx7cPan2vs2DWomIQsiNyXdx73Fbq_-qZfo-HyqpFvQDVfJnvdp7CHdg6Pvv4FwnDnKQ |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+volcanic+explosion+of+autoantibodies+in+systemic+lupus+erythematosus%3A+A+diversity+of+180+different+antibodies+found+in+SLE+patients&rft.jtitle=Autoimmunity+reviews&rft.au=Yaniv%2C+Gal&rft.au=Twig%2C+Gilad&rft.au=Shor%2C+Dana+Ben-Ami&rft.au=Furer%2C+Ariel&rft.date=2015-01-01&rft.issn=1568-9972&rft.volume=14&rft.issue=1&rft.spage=75&rft.epage=79&rft_id=info:doi/10.1016%2Fj.autrev.2014.10.003&rft.externalDBID=ECK1-s2.0-S1568997214002158&rft.externalDocID=1_s2_0_S1568997214002158 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F15689972%2FS1568997214X00108%2Fcov150h.gif |